Table 3. Expression of LncRNA and BDH2 in ESCC cases.
| Parameter | n | LncRNA | BDH2 | ||
|---|---|---|---|---|---|
| Expression level | P value | Expression level | P value | ||
| Gender | |||||
| Male | 39 | 0.53±0.179 | 0.611 | 0.23±0.068 | 0.390 |
| Female | 21 | 0.51±0.118 | 0.24±0.053 | ||
| Age(years) | |||||
| <60 | 21 | 0.49±0.171 | 0.297 | 0.23±0.066 | 0.941 |
| ≥60 | 39 | 0.54±0.153 | 0.23±0.63 | ||
| Location | |||||
| Low | 13 | 0.43±0.183 | 0.022* | 0.23±0.066 | 0.609 |
| Middle | 47 | 0.54±0.145 | 0.24±0.062 | ||
| Differentiation | |||||
| Well | 17 | 0.50±0.181 | 0.760 | 0.24±0.071 | 0.799 |
| Moderate | 32 | 0.52±0.135 | 0.23±0.060 | ||
| Poor | 11 | 0.55±0.199 | 0.24±0.064 | ||
| TNM stage | |||||
| I | 17 | 0.43±0.095 | 0.017* | 0.20±0.045 | 0.024* |
| II | 30 | 0.52±0.163 | 0.24±0.069 | ||
| III | 13 | 0.57±0.181 | 0.26±0.061 | ||
| Lymph node metastasis | |||||
| Negative | 40 | 0.51±0.161 | 0.430 | 0.23±0.063 | 0.977 |
| Positive | 20 | 0.54±0.158 | 0.23±0.065 | ||
Indicated statistical significance (P<0.05)